RESEARCH-USE BIOSIMILAR ANTIBODY
Serplulimab
Monoclonal antibody · IgG4
Serplulimab (HLX 10) is a humanized anti-PD-1 monoclonal antibody. Serplulimab can inhibit tumor growth, regulate the tumor microenvironment, and has anti-tumor activity. Serplulimab can be used in the research of cancer such as lung cancer and colon cancer.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-176
CATALOG NUMBERSC-BS-176
MOLECULAR WEIGHTApprox. 144.18 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Serplulimab (HLX 10) is a humanized anti-PD-1 monoclonal antibody. Serplulimab can inhibit tumor growth, regulate the tumor microenvironment, and has anti-tumor activity. Serplulimab can be used in the research of cancer such as lung cancer and colon cancer.
Serplulimab is a recombinant research-use antibody directed against PDCD1.